Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
07/1997
07/03/1997WO1997023620A1 Novel tcts response regulator of staphylococcus aureus
07/03/1997WO1997023614A1 Osteoprotegerin
07/03/1997WO1997023613A2 Cell activation process and reagents therefor
07/03/1997WO1997023611A2 Nucleic acid sequences of genes of the high mobility group proteins and uses thereof
07/03/1997WO1997023598A2 A long qt syndrome gene which encodes kvlqt1 and its association with mink
07/03/1997WO1997023510A1 Anti-idiotypic antibodies of vascular endothelial growth factor and use thereof as drugs
07/03/1997WO1997023509A1 ANTIFACTOR Xa-TISSUE FACTOR PATHWAY INHIBITOR COMPLEX MONOCLONAL ANTIBODY AND USE OF THE SAME
07/03/1997WO1997023507A2 New form of amphiregulin, methods for producing and using the same and compositions comprising the same
07/03/1997WO1997023505A1 Two component signal transducing system protein from staphylococcus aureus
07/03/1997WO1997023504A1 Two-component signal transduction response regulator polypeptides from staphylococcus aureus
07/03/1997WO1997023237A1 Use of immunoconjugates to enhance the efficacy of multi-stage cascade boosting vaccines
07/03/1997CA2241924A1 Methods for measurement and treatment predicated on the presence of advanced glycosylation endproducts in tobacco and its combustion byproducts
07/03/1997CA2241105A1 Staphylococcus aureus coenzyme a disulfide reductase, and inhibitors thereof useful as antimicrobial agents
07/03/1997CA2241023A1 Novel polynucleotides and polypeptides in pathogenic mycobacteria and their use as diagnostics, vaccines and targets for chemotherapy
07/03/1997CA2240834A1 Use of immunoconjugates to enhance the efficacy of multi-stage cascade boosting vaccines
07/03/1997CA2239682A1 Nucleic acid sequences of genes of the high mobility group proteins and uses thereof
07/03/1997CA2238873A1 Cell activation process and reagents therefor
07/03/1997CA2237543A1 New form of amphiregulin, methods for producing and using the same and compositions comprising the same
07/02/1997EP0781847A1 Humanized monoclonal antibody
07/02/1997EP0781845A2 Anti-human milk fat globule humanised antibodies and processes for their production
07/02/1997EP0781779A2 Nonantigenic stabilizer and physiologically active substance
07/02/1997EP0781560A1 Use of immunoglobulin preparations for the production of a drug for oral administration for treatment and prophylaxis of chronic pain conditions
07/02/1997EP0781414A1 Diagnostic test for proliferative senescence in immune cells
07/02/1997EP0781344A1 Novel implant and novel vector for the treatment of acquired diseases
07/02/1997EP0781337A1 Humanised antibody to integrin chain beta-1
07/02/1997EP0781336A1 A human map kinase homolog
07/02/1997EP0781297A1 Cytotactin derivatives that stimulate attachment and neurite outgrowth, and methods of making and using same
07/02/1997EP0781296A1 ACTIVE INDUCTION OR PASSIVE IMMUNIZATION OF ANTI-gp48 ANTIBODIES AND ISOLATED gp48 PROTEIN
07/02/1997EP0781140A1 Corticotropin release inhibiting factor and methods of using same
07/02/1997EP0702720A4 Method for defined deletions of dna
07/02/1997EP0689552A4 A method of detecting rupture of the amniotic membranes in pregant mammals
07/02/1997EP0627000A4 Mammalian expression systems for hcv proteins.
07/02/1997CN1153529A Hepatitis G virus and molecular cloning thereof
07/02/1997CN1153063A Method of recovering immunoglobulin from fractions produced during fractionation of human blood plasma
07/01/1997US5644047 Compositions for diagnosing rochalimaea henselae and rochalimaea quintana infection
07/01/1997US5644036 Purified immunoglobulin
07/01/1997US5644035 Method for purifying secreted Mac-2-binding glycoprotein
07/01/1997US5644034 Tumour necrosis factor binding ligands
07/01/1997US5644033 Monoclonal antibodies that define a unique antigen of human B cell antigen receptor complex and methods of using same for diagnosis and treatment
07/01/1997US5644031 Delta-like gene expressed in neuroendocrine tumors
07/01/1997US5644030 Gene and method for production of an IgA binding protein
07/01/1997US5643785 Polynucleotides encoding AMPA-binding human GluR4 receptors
07/01/1997US5643781 DNA encoding protocadherin-42
07/01/1997US5643778 RNA editing enzyme and methods of use thereof
07/01/1997US5643772 Cryptosporidium hybrid vector and transformed host cells
07/01/1997US5643759 Hybridoma cell lines
07/01/1997US5643754 Nucleic acids encoding a leptospira outer membrane protein
07/01/1997US5643752 Culture of cells to produce polypeptides
07/01/1997US5643749 Soluble interferon α-receptor, its preparation and use
07/01/1997US5643748 HU-B1.219, a novel human hematopoietin receptor
07/01/1997US5643740 Diagnostic and therapeutic uses in cancer, autoimmune disease and transplant rejection
07/01/1997US5643737 Merozoite proteins for use in detection of Babesia equi in horses using immunological techniques
07/01/1997US5643736 Hybridomas and detection of osteogenic cell subsets
07/01/1997US5643735 Anti-thymosin α1 monoclonal antibody-producing hybridoma
07/01/1997US5643714 Method and assay for HTLV
07/01/1997US5643573 Drug delivery
07/01/1997US5643572 Monoclonal antibody to urushiol
07/01/1997US5643571 Adding immunized fish which release antibodies against pathogenic organisms such as protozoa and parasites
07/01/1997US5643550 Method of treating colorectal carcinoma lesion and composition for use therein
07/01/1997CA2128248C Amino acids useful as inhibitors of the advanced glycosylation of proteins
06/1997
06/26/1997WO1997022972A2 Method for the simultaneous detection of a therapeutic target for a disease state and its neutralizing antibody-like molecule
06/26/1997WO1997022880A1 Use of rc-9 in diagnosis and treatment of proliferative arterial disease
06/26/1997WO1997022702A1 Diagnosis and treatment of aur-1 and/or aur-2 related disorders
06/26/1997WO1997022699A2 Murine monoclonal anti-idiotype antibody 11d10 an methods of use thereof
06/26/1997WO1997022698A2 Chemokine receptors 88-2b[ckr-3] and 88c and their antibodies
06/26/1997WO1997022697A1 TGFβ SIGNAL TRANSDUCTION PROTEINS, GENES, AND USES RELATED THERETO
06/26/1997WO1997022695A2 Nucleotide sequences, proteins, drugs and diagnostic agents for treating cancer
06/26/1997WO1997022690A2 SIGNALING INOSITOL POLYPHOSPHATE 5-PHOSPHATASES (SIPs)
06/26/1997WO1997022623A1 Osteo antiviral protein
06/26/1997WO1997022363A2 Improved pharmaceutical compositions
06/26/1997WO1997022361A1 Sugar chain-recognizing antibody and remedy for infection with hiv
06/26/1997WO1997007225A3 High efficiency retroviral packaging system
06/26/1997DE19548122A1 Nukleinsäuresequenzen von Genen der High Mobility Group Proteine sowie Verwendungen derselben Nucleic acid sequences of genes of the high mobility group proteins and uses thereof
06/26/1997DE19547416A1 New monoclonal antibodies specific for proteosomes
06/26/1997DE19547324A1 cDNA encoding human mucin 8
06/26/1997CA2241040A1 Improved pharmaceutical compositions
06/26/1997CA2240449A1 Nucleotide sequences, proteins, drugs and diagnostic agents for treating cancer
06/26/1997CA2239126A1 Tgf.beta. signal transduction proteins, genes, and uses related thereto
06/25/1997EP0779982A1 Screening method for periodontal disease
06/25/1997EP0779933A1 Methods for producing antibody libraries using universal or randomized immunoglobulin light chains
06/25/1997EP0779923A2 Interleukin-1 type 3 receptors
06/25/1997EP0779897A1 METHOD OF PRODUCING SINGLE-CHAIN Fv MOLECULES
06/25/1997EP0779819A1 Therapeutic treatment of clostridium difficile associated diseases
06/25/1997EP0623145B1 Peptides of the casein macropeptide, antibodies directed against said peptides, and applications
06/25/1997CN1152939A Monoclonal antibodies which promote central nervous system remyelination
06/25/1997CN1152925A Monoclonal antibody active against CD44V6
06/25/1997CN1152877A Conjugate between a modified superantigen and a target-seeking compound and the use of the conjugate
06/24/1997US5641870 Low pH hydrophobic interaction chromatography for antibody purification
06/24/1997US5641869 Fractionation on immunoaffinity or ion exchange column, ethanol or ammonium sulfate precipitation, reverse phase liquid chromatography, chromatography on silica or heparin sepharose, chromatofocusing, gel filtration, electrophoresis
06/24/1997US5641867 Antitumor agents
06/24/1997US5641866 Bcl-2-associated proteins
06/24/1997US5641865 Surfactant stabilized microheterogeneous dispersion of aqueous phase containing antibody or fragment thereof in water immiscible medium
06/24/1997US5641860 A glycoprotein useful in the diagnosis of t-lymphoblastic lymphoma and leukemia
06/24/1997US5641837 Method of detecting collagen degradation in vivo
06/24/1997US5641760 Method of treating candida infection
06/24/1997US5641747 Treatment of osteopetrotic diseases
06/24/1997US5641687 Contacting body fluid with immunological binding partner which binds to specified crosslinked collagen telopeptide, detecting binding, correlating with collagen degradation
06/24/1997US5641677 Method of enhancing the immunotherapeutic activity of immune cells by depletion of CD8+ T cells
06/24/1997US5641669 Platelet-activating factor acetylhydrolase
06/24/1997US5641638 Monoclonal antibodies against Mycoplasma pneumoniae, hybridomas producing these, methods for the preparation thereof, and the use thereof